Bisphosphonate-related osteonecrosis of the jaws – Characteristics, risk factors, clinical features, localization and impact on oncological treatment
Top Cited Papers
- 15 June 2011
- journal article
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 40 (4), 303-309
- https://doi.org/10.1016/j.jcms.2011.05.003
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Is Zoledronate Toxic to Human Periodontal Fibroblasts?Journal of Dental Research, 2009
- The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few DataJournal of Oral and Maxillofacial Surgery, 2009
- Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignanciesOral Oncology, 2008
- “Bis-phossy jaws” – High and low risk factors for bisphosphonate-induced osteonecrosis of the jawJournal of Cranio-Maxillofacial Surgery, 2008
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2007
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple MyelomaJournal of Clinical Oncology, 2002
- III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal OsteoporosisEndocrine Reviews, 2002
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996